PLK4 and neoplasm: (2) KIF2A also exacerbates the proliferation and reduces the apoptosis of cancer cells by inhibiting the PLK4/miR-129-5p axis or the PI3K/Akt signaling pathway (30, 32), resulting in the larger tumor size in BLBC patients.